Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-25 7:01 pm Sale | 2024-03-31 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 302,766 5.140% | -22,939 (-7.04%) | Filing History |
| 2024-04-25 6:52 pm Sale | 2024-03-31 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 20,112 3.670% | -10,848 (-35.04%) | Filing History |
| 2024-03-25 6:55 pm Purchase | 2024-03-19 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,952,202 9.900% | 541,678 (+22.47%) | Filing History |
| 2024-03-21 09:05 am Unchanged | 2024-03-20 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 504,261 9.900% | 0 (Unchanged) | Filing History |
| 2024-03-20 9:21 pm Purchase | 2024-03-20 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 504,261 9.900% | 504,261 (New Position) | Filing History |
| 2024-03-01 12:19 pm Purchase | 2024-02-13 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 415,800 9.950% | 415,800 (New Position) | Filing History |
| 2024-02-22 4:28 pm Sale | 2023-12-31 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 325,705 4.400% | -103,295 (-24.08%) | Filing History |
| 2024-02-20 1:42 pm Sale | 2023-12-31 | 13G | Guided Therapeutics, Inc. GTHP | Rosalind Advisors Inc. | 0 0.000% | -2,338,740 (Position Closed) | Filing History |
| 2024-02-20 1:38 pm Sale | 2023-12-31 | 13G | SIENTRA INC SIENQ | Rosalind Advisors Inc. | 0 0.000% | -509,274 (Position Closed) | Filing History |
| 2024-02-15 10:42 am Unchanged | 2023-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.200% | 0 (Unchanged) | Filing History |
| 2024-02-14 9:40 pm Purchase | 2023-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 4,575,385 9.200% | 4,022,095 (+726.94%) | Filing History |
| 2024-02-14 9:33 pm Unchanged | 2023-12-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 8,988,318 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:48 pm Purchase | 2023-12-31 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 479,990 5.200% | 479,990 (New Position) | Filing History |
| 2024-02-14 8:43 pm Purchase | 2023-12-31 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 479,990 5.200% | 35,664 (+8.03%) | Filing History |
| 2024-02-14 8:31 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 222,564 9.900% | 150,622 (+209.36%) | Filing History |
| 2024-01-30 11:06 am Purchase | 2024-01-24 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 30,960 5.670% | 30,960 (New Position) | Filing History |
| 2023-11-28 4:53 pm Sale | 2023-11-17 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,410,524 9.900% | -102,227 (-4.07%) | Filing History |
| 2023-08-28 1:46 pm Purchase | 2023-08-25 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,333,334 9.800% | 7,333,334 (New Position) | Filing History |
| 2023-07-27 6:09 pm Purchase | 2023-07-11 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 429,000 5.800% | 429,000 (New Position) | Filing History |
| 2023-06-07 5:33 pm Purchase | 2023-06-01 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 8,988,318 9.900% | 8,988,318 (New Position) | Filing History |